Genetic Technologies Ltd
ASX:GTG
Genetic Technologies Ltd
ASX:GTG
Price:
0.039
AUD
Market Closed
Market Cap:
AU$52.1m
Relative Value
The Relative Value of one
GTG
stock under the Base Case scenario is
0.027
AUD.
Compared to the current market price of 0.039 AUD,
Genetic Technologies Ltd
is
Overvalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GTG
Relative Value
Base Case
0.027
AUD
Overvaluation 30%
Multiples Across Competitors
GTG Competitors Multiples
Genetic Technologies Ltd Competitors
Genetic Technologies Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Genetic Technologies Ltd
ASX:GTG
|
52.1m AUD | 14.1 | -5.4 | -7.4 | -7.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 368.3 | 4 361 | 1 382.7 | 2 954.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.3B USD | 4.4 | 29.1 | 20.3 | 27.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
147.9B USD | 6 | 40.9 | 22.7 | 34.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 14.4 | 49.6 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.7B CHF | 5.6 | 38.7 | 28.6 | 28.6 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280.9B CNY | 6.3 | 18.7 | 18.9 | 18.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.3B USD | 4.9 | 26.3 | 19.2 | 22.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.9B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.8B USD | 6.9 | 32 | 23.6 | 26.2 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.2B HKD | 7.2 | 34.4 | 24.1 | 24.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
